product summary
Loading...
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
Mouse anti Rat RECA-1
catalog :
MCA970R
quantity :
0.25 mg
price :
394 USD
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
HIS52
reactivity :
mouse, rat
application :
immunohistochemistry, immunocytochemistry, immunohistochemistry - paraffin section, immunohistochemistry - frozen section, immunohistochemistry - free floating section, other
more info or order :
citations: 45
Published Application/Species/Sample/DilutionReference
  • immunohistochemistry; rat; loading ...
Rodionova K, Fiedler C, Guenther F, Grouzmann E, Neuhuber W, Fischer M, et al. Complex reinnervation pattern after unilateral renal denervation in rats. Am J Physiol Regul Integr Comp Physiol. 2016;310:R806-18 pubmed publisher
  • immunohistochemistry - frozen section; rat; fig 2
Wang J, Lin G, Alwaal A, Zhang X, Wang G, Jia X, et al. Kinetics of Label Retaining Cells in the Developing Rat Kidneys. PLoS ONE. 2015;10:e0144734 pubmed publisher
  • immunohistochemistry; rat; 1:1000; fig 4
Vidal Sanz M, Valiente Soriano F, Ortín Martínez A, Nadal Nicolás F, Jiménez López M, Salinas Navarro M, et al. Retinal neurodegeneration in experimental glaucoma. Prog Brain Res. 2015;220:1-35 pubmed publisher
  • immunohistochemistry - frozen section; rat; 1:300; fig 4
Lemasson B, Bouchet A, Maisin C, Christen T, Le Duc G, Rémy C, et al. Multiparametric MRI as an early biomarker of individual therapy effects during concomitant treatment of brain tumours. NMR Biomed. 2015;28:1163-73 pubmed publisher
  • other; rat; loading ...; fig 2a; 3a
Imberti B, Corna D, Rizzo P, Xinaris C, Abbate M, Longaretti L, et al. Renal primordia activate kidney regenerative events in a rat model of progressive renal disease. PLoS ONE. 2015;10:e0120235 pubmed publisher
  • immunohistochemistry - paraffin section; rat; 1:50
Matsushita T, Lankford K, Arroyo E, Sasaki M, Neyazi M, Radtke C, et al. Diffuse and persistent blood-spinal cord barrier disruption after contusive spinal cord injury rapidly recovers following intravenous infusion of bone marrow mesenchymal stem cells. Exp Neurol. 2015;267:152-64 pubmed publisher
  • immunohistochemistry - free floating section; rat; 1:300
Paniagua Torija B, Arevalo Martin A, Molina Holgado E, Molina Holgado F, Garcia Ovejero D. Spinal cord injury induces a long-lasting upregulation of interleukin-1β in astrocytes around the central canal. Neuroscience. 2015;284:283-9 pubmed publisher
  • immunohistochemistry; mouse; 1:1000
Milesi S, Boussadia B, Plaud C, Catteau M, Rousset M, de Bock F, et al. Redistribution of PDGFR? cells and NG2DsRed pericytes at the cerebrovasculature after status epilepticus. Neurobiol Dis. 2014;71:151-8 pubmed publisher
  • immunohistochemistry - free floating section; rat; 1:250
Kawamura K, Takahashi T, Kanazawa M, Igarashi H, Nakada T, Nishizawa M, et al. Effects of angiopoietin-1 on hemorrhagic transformation and cerebral edema after tissue plasminogen activator treatment for ischemic stroke in rats. PLoS ONE. 2014;9:e98639 pubmed publisher
Takamori Y, Hirahara Y, Wakabayashi T, Mori T, Koike T, Kataoka Y, et al. Differential expression of nuclear lamin subtypes in the neural cells of the adult rat cerebral cortex. IBRO Rep. 2018;5:99-109 pubmed publisher
Takahashi T, Fujimura M, Koyama M, Kanazawa M, Usuki F, Nishizawa M, et al. Methylmercury Causes Blood-Brain Barrier Damage in Rats via Upregulation of Vascular Endothelial Growth Factor Expression. PLoS ONE. 2017;12:e0170623 pubmed publisher
Skardelly M, Gaber K, Burdack S, Scheidt F, Schuhmann M, Hilbig H, et al. Transient but not permanent benefit of neuronal progenitor cell therapy after traumatic brain injury: potential causes and translational consequences. Front Cell Neurosci. 2014;8:318 pubmed publisher
Bouchet A, Bidart M, Miladi I, Le Clec h C, Serduc R, Coutton C, et al. Characterization of the 9L gliosarcoma implanted in the Fischer rat: an orthotopic model for a grade IV brain tumor. Tumour Biol. 2014;35:6221-33 pubmed publisher
Guzmán Hernández M, Potter G, Egervari K, Kiss J, Balla T. Secretion of VEGF-165 has unique characteristics, including shedding from the plasma membrane. Mol Biol Cell. 2014;25:1061-72 pubmed publisher
Nakamura K, Hatano E, Miyagawa Hayashino A, Okuno M, Koyama Y, Narita M, et al. Soluble thrombomodulin attenuates sinusoidal obstruction syndrome in rat through suppression of high mobility group box 1. Liver Int. 2014;34:1473-87 pubmed publisher
Friedrich V, Bederson J, Sehba F. Gender influences the initial impact of subarachnoid hemorrhage: an experimental investigation. PLoS ONE. 2013;8:e80101 pubmed publisher
Streijger F, Plunet W, Lee J, Liu J, Lam C, Park S, et al. Ketogenic diet improves forelimb motor function after spinal cord injury in rodents. PLoS ONE. 2013;8:e78765 pubmed publisher
Botfield H, Gonzalez A, Abdullah O, Skjolding A, Berry M, McAllister J, et al. Decorin prevents the development of juvenile communicating hydrocephalus. Brain. 2013;136:2842-58 pubmed publisher
Bouchet A, Lemasson B, Christen T, Potez M, Rome C, Coquery N, et al. Synchrotron microbeam radiation therapy induces hypoxia in intracerebral gliosarcoma but not in the normal brain. Radiother Oncol. 2013;108:143-8 pubmed publisher
Guptarak J, Wanchoo S, Durham Lee J, Wu Y, Zivadinovic D, Paulucci Holthauzen A, et al. Inhibition of IL-6 signaling: A novel therapeutic approach to treating spinal cord injury pain. Pain. 2013;154:1115-28 pubmed publisher
Karadimas S, Moon E, Yu W, Satkunendrarajah K, Kallitsis J, Gatzounis G, et al. A novel experimental model of cervical spondylotic myelopathy (CSM) to facilitate translational research. Neurobiol Dis. 2013;54:43-58 pubmed publisher
Palin N, Savikko J, Koskinen P. Sirolimus inhibits lymphangiogenesis in rat renal allografts, a novel mechanism to prevent chronic kidney allograft injury. Transpl Int. 2013;26:195-205 pubmed publisher
Nguyen D, Cho N, Satkunendrarajah K, Austin J, Wang J, Fehlings M. Immunoglobulin G (IgG) attenuates neuroinflammation and improves neurobehavioral recovery after cervical spinal cord injury. J Neuroinflammation. 2012;9:224 pubmed publisher
Krebs R, Tikkanen J, Ropponen J, Jeltsch M, Jokinen J, Yla Herttuala S, et al. Critical role of VEGF-C/VEGFR-3 signaling in innate and adaptive immune responses in experimental obliterative bronchiolitis. Am J Pathol. 2012;181:1607-20 pubmed publisher
Karimi Abdolrezaee S, Schut D, Wang J, Fehlings M. Chondroitinase and growth factors enhance activation and oligodendrocyte differentiation of endogenous neural precursor cells after spinal cord injury. PLoS ONE. 2012;7:e37589 pubmed publisher
Durham Lee J, Wu Y, Mokkapati V, Paulucci Holthauzen A, Nesic O. Induction of angiopoietin-2 after spinal cord injury. Neuroscience. 2012;202:454-64 pubmed publisher
Lauritzen F, Perez E, Melillo E, Roh J, Zaveri H, Lee T, et al. Altered expression of brain monocarboxylate transporter 1 in models of temporal lobe epilepsy. Neurobiol Dis. 2012;45:165-76 pubmed publisher
Friedrich V, Flores R, Muller A, Bi W, Peerschke E, Sehba F. Reduction of neutrophil activity decreases early microvascular injury after subarachnoid haemorrhage. J Neuroinflammation. 2011;8:103 pubmed publisher
Wakabayashi T, Mori T, Hirahara Y, Koike T, Kubota Y, Takamori Y, et al. Nuclear lamins are differentially expressed in retinal neurons of the adult rat retina. Histochem Cell Biol. 2011;136:427-36 pubmed publisher
Lemasson B, Christen T, Tizon X, Farion R, Fondraz N, Provent P, et al. Assessment of multiparametric MRI in a human glioma model to monitor cytotoxic and anti-angiogenic drug effects. NMR Biomed. 2011;24:473-82 pubmed publisher
Hayward N, Immonen R, Tuunanen P, Ndode Ekane X, Gröhn O, Pitkanen A. Association of chronic vascular changes with functional outcome after traumatic brain injury in rats. J Neurotrauma. 2010;27:2203-19 pubmed publisher
Liu W, Jin H, Park J, Baek H, Park T. Effect of rimonabant, the cannabinoid CB1 receptor antagonist, on peripheral nerve in streptozotocin-induced diabetic rat. Eur J Pharmacol. 2010;637:70-6 pubmed publisher
Gray S, Blake B, Criswell H, Nicolson S, Samulski R, McCown T, et al. Directed evolution of a novel adeno-associated virus (AAV) vector that crosses the seizure-compromised blood-brain barrier (BBB). Mol Ther. 2010;18:570-8 pubmed publisher
Ndode Ekane X, Hayward N, GROHN O, Pitkanen A. Vascular changes in epilepsy: functional consequences and association with network plasticity in pilocarpine-induced experimental epilepsy. Neuroscience. 2010;166:312-32 pubmed publisher
Friedrich V, Flores R, Muller A, Sehba F. Escape of intraluminal platelets into brain parenchyma after subarachnoid hemorrhage. Neuroscience. 2010;165:968-75 pubmed publisher
Ciofi P, Garret M, Lapirot O, Lafon P, Loyens A, Prevot V, et al. Brain-endocrine interactions: a microvascular route in the mediobasal hypothalamus. Endocrinology. 2009;150:5509-19 pubmed publisher
Helle F, Jouzel C, Chadjichristos C, Placier S, Flamant M, Guerrot D, et al. Improvement of renal hemodynamics during hypertension-induced chronic renal disease: role of EGF receptor antagonism. Am J Physiol Renal Physiol. 2009;297:F191-9 pubmed publisher
Bexell D, Gunnarsson S, Siesjo P, Bengzon J, Darabi A. CD133+ and nestin+ tumor-initiating cells dominate in N29 and N32 experimental gliomas. Int J Cancer. 2009;125:15-22 pubmed publisher
Araneda S, Commin L, Atlagich M, Kitahama K, Parraguez V, Pequignot J, et al. VEGF overexpression in the astroglial cells of rat brainstem following ozone exposure. Neurotoxicology. 2008;29:920-7 pubmed publisher
Belabbas H, Zalvidea S, Casellas D, Moles J, Galbes O, Mercier J, et al. Contrasting effect of exercise and angiotensin II hypertension on in vivo and in vitro cardiac angiogenesis in rats. Am J Physiol Regul Integr Comp Physiol. 2008;295:R1512-8 pubmed publisher
Malmström N, Kallio E, Rintala J, Nykänen A, Räisänen Sokolowski A, Paavonen T, et al. Vascular endothelial growth factor in chronic rat allograft nephropathy. Transpl Immunol. 2008;19:136-44 pubmed publisher
Kao H, Li P, Chao H, Janoschka S, Pham K, Feng J, et al. Early involvement of synapsin III in neural progenitor cell development in the adult hippocampus. J Comp Neurol. 2008;507:1860-70 pubmed publisher
Kim J, Lim C, Yu Y, Lee J. Induction and subcellular localization of high-mobility group box-1 (HMGB1) in the postischemic rat brain. J Neurosci Res. 2008;86:1125-31 pubmed
Ciofi P, Lapirot O, Tramu G. An androgen-dependent sexual dimorphism visible at puberty in the rat hypothalamus. Neuroscience. 2007;146:630-42 pubmed
Takeda S, Rogers S, Hammerman M. Differential origin for endothelial and mesangial cells after transplantation of pig fetal renal primordia into rats. Transpl Immunol. 2006;15:211-5 pubmed
image
image 1 :
Bio-Rad MCA970R image 1
Published customer image: . Mouse anti Rat RECA-1 antibody, clone HIS52 ( MCA970R ) used for the detection of RECA-1 expressing cells by immunofluorescence. Image caption . Transduction of AdV-eGFP/AdV-ZFP-VEGF into the spinal cord. (A) Photomicrographs showing a transverse section of rat spinal cord obtained adjacent to the injury site 10 days after spinal cord injury and AdV-eGFP injection. eGFP signal was detected in both the gray matter and white matter. (B) High-power (63X) confocal images show that the AdV-eGFP vector (green) transfected neurons (NeuN), astrocytes (GFAP), oligodendrocytes (CC1) and endothelial cells (RECA-1). Cells have been counter-stained with DAPI (blue) as nuclear marker. (C) Bar graph displays quantification of transduced cell types ± SEM, as identified by the cell-specific markers NeuN, GFAP, RECA-1 and CC1. (D) Evaluation of AdV-ZFP-VEGF gene transfer. Western blot showed that the NF B p65 rabbit polyclonal antibody recognizes the p65 activation domain in the AdV-ZFP-VEGF treated animals. The higher molecular weight bands are endogenous NF Bp65 fragments, which are also recognized by the antibody; however, these bands are present in both the control and treatment groups. The lower band (arrow) corresponds to the AdV-ZFP-VEGF and was only present in the treated animals. Lower panel shows actin expression as a protein control. Scale bar: 1000 um for A; 100 um for B. From: Figley SA, Liu Y, Karadimas SK, Satkunendrarajah K, Fettes P, et al. (2014). Delayed Administration of a Bio-Engineered Zinc-Finger VEGF-A Gene Therapy Is Neuroprotective and Attenuates Allodynia Following Traumatic Spinal Cord Injury. PLoS ONE 9(5): e96137 .
product information
Entity Type :
Monoclonal Antibody
Entity Category :
Antibodies
ProductCode :
MCA970R
Description :
Mouse anti Rat RECA-1
Specificity :
RECA-1
TargetSpecies :
Rat
Host :
Mouse
Format :
Purified
Isotypes :
IgG1
Applications :
IF,C
ApplicationTypes :
Immunofluorescence,Immunohistology - Frozen
Cross Reactivities :
Goat,Chicken,Guinea Pig,Sheep,Mouse,Rabbit,Pig
Clone :
HIS52
Quantity :
0.25 mg
Quantity Value :
0.25
Quantity Type :
mg
Entity Formats :
Purified
UNSPSC :
41116161
Concentration :
IgG concentration 0.5 mg/ml
Product Form :
Purified IgG - liquid
PriceGBP :
281
PriceEUR :
394
PriceUSD :
394 USD
PriceCHF :
429
PriceSEK :
4295
PriceNOK :
4316
PriceDKK :
2938
more info or order :
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com
1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.